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Background:  Data  regarding  the  relationship  between  systolic  blood  pressure  (SBP)  at admission  and  in-
hospital  outcome  in  patients  with  acute  myocardial  infarction  (AMI)  undergoing  primary  percutaneous
coronary  intervention  (PCI)  are  still  lacking  in Japan.
Methods  and results:  A  total  of  1475  primary  PCI-treated  AMI patients  were  classiﬁed  into  quin-
tiles  based  on  admission  SBP  (<105  mmHg,  n  = 300;  105–125  mmHg,  n = 294;  126–140 mmHg,  n  =  306;
141–158  mmHg,  n =  286;  and  ≥159  mmHg  n  =  289).  The  patients  with  SBP  < 105 mmHg  tended  to  have
higher  age,  previous  myocardial  infarction,  chronic  kidney  disease  (CKD),  Killip  class  ≥  3 at  admission,
right  coronary  artery,  left main  trunk  (LMT),  or multivessels  as  culprit  lesions,  larger  number  of  diseased
vessels,  lower  Thrombolysis  In Myocardial  Infarction  (TIMI)  grade  in the  infarct-related  artery  before  pri-
mary PCI, and  higher  value  of  peak  creatine  phosphokinase  concentration.  Patients  with  SBP  < 105  mmHg
had  a signiﬁcantly  higher  mortality,  while  mortality  was  not  signiﬁcantly  different  among  the  other
quintiles:  24.3%  (<105  mmHg),  4.8%  (105–125  mmHg),  4.9%  (126–140  mmHg),  2.8%  (141–158  mmHg),
and  5.2%  (≥159  mmHg)  (p  < 0.001).  On  multivariate  analysis,  Killip  class  ≥  3  at admission,  LMT  or  mul-
tivessels  as  culprit  lesions,  admission  SBP  < 105  mmHg,  CKD,  and  age  were  the  independent  positive
predictors  of  in-hospital  mortality,  whereas  admission  SBP  141–158  mmHg  and TIMI  3  ﬂow  after  PCI  were
the  negative  ones,  but  admission  SBP  105–125  mmHg,  admission  SBP  126–140  mmHg,  and  admission
SBP  ≥ 159  mmHg  were  not.
Conclusions:  These  results  suggest  that  admission  SBP  141–158  mmHg  might  be  correlated  with  bet-
ter  in-hospital  prognosis,  whereas  admission  SBP  <  105 mmHg  was  associated  with  in-hospital  death  in
dergo
2  JapJapanese  AMI  patients  un
©  201
ntroductionPrimary percutaneous coronary intervention (PCI) is now estab-
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myocardial infarction (AMI) and accumulating clinical evidence has
shown that primary PCI can improve the prognosis in AMI  patients
suffering from cardiogenic shock [1–4]. Even in the primary PCI
era, however, AMI  complicated with cardiogenic shock remains a
deteriorating condition with high in-hospital morbidity and mor-
tality. Numerous reports from the USA and European investigators
have demonstrated that in AMI  patients, there is an inverse rela-
tionship between systolic blood pressure (SBP) at admission and
in-hospital mortality, and admission SBP is an independent predic-
tor of in-hospital death [5–8]. In contrast, we  have recently shown
that in overall AMI  patients with elapsed time < 24 h, admission SBP
vier Ltd. All rights reserved.
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41–159 mmHg  might be correlated with better in-hospital prog-
osis, whereas admission SBP < 106 mmHg  was associated with
n-hospital death [9]. However, the relationship between admis-
ion SBP, clinical manifestations, and in-hospital outcome in AMI
atients undergoing primary PCI remains uncertain. The AMI-Kyoto
ulti-Center Risk Study, a large multicenter observational study in
hich collaborating hospitals in Kyoto Prefecture have collected
emographic, procedural, and outcome data on AMI  patients, was
stablished in 2000 in order to analyze these data and establish an
mergency-hospital network for heart diseases in Kyoto [9,10].  The
urpose of the present study was therefore to examine the prognos-
ic impact of admission SBP on in-hospital outcome in Japanese AMI
atients undergoing primary PCI, using data from the AMI-Kyoto
ulti-Center Risk Study.
ethods
atient population
From July 2006 to December 2010, 1636 consecutive patients
ith a diagnosis of AMI, who were admitted to AMI-Kyoto Multi-
enter Risk Study Group Hospitals within 24 h after the onset of
MI, were enrolled in the present study. Of these, 1481 patients
nderwent primary PCI, of whom data on clinical background
nd SBP at admission were available for 1475. The 1475 primary
CI-treated AMI  patients were classiﬁed into quintiles based on
BP at hospital admission (<105 mmHg, n = 300; 105–125 mmHg,
 = 294; 126–140 mmHg, n = 306; 141–158 mmHg, n = 286; and
159 mmHg, n = 289). Systolic blood pressure at admission was
eﬁned as SBP ﬁrst recorded in supine position or sitting position
ust after presentation to the emergency room or the outpatient
linic. We  retrospectively compared clinical background, coronary
isk factors, angiographic ﬁndings, acute results of primary PCI, and
n-hospital prognosis among the 5 groups. The diagnosis of AMI
equired the presence of 2 of the following 3 criteria: (1) charac-
eristic clinical history; (2) serial changes on the electrocardiogram
uggesting infarction (Q-waves) or injury (ST-segment elevations);
nd (3) transient increase in cardiac enzymes to more than 2-fold
he normal laboratory value.
ata collection
The patients’ demographic information, cardiovascular history,
nd risk factors (i.e. smoking, hypercholesterolemia, hypertension,
nd diabetes mellitus) were recorded. Hypercholesterolemia was
eﬁned as total cholesterol ≥ 220 mg/dl or the use of cholesterol-
owering agents; hypertension was deﬁned as systemic blood
ressure ≥ 140/90 mmHg  or the use of antihypertensive treatment;
iabetes mellitus was deﬁned as fasting blood sugar ≥ 126 mg/dl
r the use of speciﬁc treatment. Chronic kidney disease (CKD)
as deﬁned as estimated glomerular ﬁltration rate (eGFR) of
ess than 60 mL/min/1.73 m2, and eGFR was calculated using
he Japanese equation, eGFR (mL/min/1.73 m2) = 194 × Serum
reatinine(−1.094) × Age(−0.287) × 0.739 (if female) [11]. After
nformed consent to participate in the AMI-Kyoto Multi-Center
isk Study was conﬁrmed by each patient, all in-hospital data
ere transmitted to the center located at the Department of
ardiovascular Medicine in Kyoto Prefectural University School of
edicine for analysis. The study protocol was approved by each
ospital’s ethics committee.
mergency coronary angiography and reperfusion therapyEmergency coronary angiography (CAG) was performed using
he standard technique. The coronary ﬂow in the infarct-related
rtery (IRA) was graded according to the classiﬁcation used in theiology 60 (2012) 139–144
Thrombolysis In Myocardial Infarction (TIMI) trial. Signiﬁcant coro-
nary artery stenosis was deﬁned as at least a 75% reduction in
the internal diameter of the right, left anterior descending, or left
circumﬂex coronary arteries and their major branches, or a 50%
reduction in the internal diameter of the left main trunk (LMT).
Non-signiﬁcant stenosis was  deﬁned as coronary arterial narrow-
ing less than a signiﬁcant stenosis. Multivessels as culprit lesions
were deﬁned as simultaneous thromboses of multiple coronary
arteries in the initial CAG. After the culprit lesions were ascertained
by CAG, primary PCI was  subsequently performed.
Endpoint measures
In-hospital death was deﬁned as all-cause death during admis-
sion period.
Statistics
Data are expressed as mean ± SD. Five groups were compared
using the chi-square test for discrete variables and Kruskal–Wallis
test or 1-way analysis of variance, followed by Scheffe’s test as the
post hoc test for continuous variables, as appropriate, according
to standard statistical methods. The odds ratio (OR) and 95% con-
ﬁdence intervals (CI) assessing the risk of in-hospital death were
estimated by univariate and multivariate analyses using logistic
regression model. Potent variables with a p-value < 0.05 on the uni-
variate analyses were entered into a multivariate analysis. In the
logistic regression analysis, TIMI ﬂow grade was categorized into
2 groups: grade 3 and grade ≤ 2 or unknown, and CKD was  cat-
egorized into 2 groups: with CKD and without CKD or without
eGFR value. In all analyses, statistical signiﬁcance was accepted at
p < 0.05.
Results
Patient characteristics and risk factors
The clinical characteristics and risk factors among the 5 groups
are summarized in Table 1. Age, heart rate at admission, and
frequency of previous myocardial infarction (MI), hypertension,
diabetes mellitus, CKD, and Killip class ≥ 3 at admission were
signiﬁcantly different among the 5 groups. The patients with
SBP < 105 mmHg  had higher age, lower heart rate, and larger preva-
lence of Killip class ≥ 3 at admission and previous MI,  while the
patients with SBP ≥ 159 mmHg had higher frequency of hyperten-
sion and diabetes mellitus.
Angiographic data
Table 2 shows the emergency CAG data for the 5 groups. The
distribution of culprit coronary artery and the number of diseased
vessels was signiﬁcantly different among the 5 groups. The patients
with SBP < 105 mmHg  were more likely to have right coronary
artery (RCA), LMT, or multivessels as culprit lesions as well as larger
number of diseased vessels or diseased LMT  on initial CAG.
Results of coronary intervention
Table 3 shows the results of primary PCI in the 5 groups. Data
on TIMI grade were available in 299 of the 300 patients with
SBP < 105 mmHg, 292 of the 294 patients with SBP 105–125 mmHg,
302 of the 306 patients with SBP 126–140 mmHg, 281 of the 286
patients with SBP 141–158 mmHg, and 285 of the 289 patients
with SBP ≥ 159 mmHg. The distribution of TIMI grade in the IRA
before primary PCI was  signiﬁcantly different among the 5 groups.
The patients with SBP < 105 mmHg  tended to have lower TIMI
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Table  1
Clinical characteristics by SBP at admission.
Systolic blood pressure at admission quintile (mmHg) p value
<105 (n = 300) 105–125 (n = 294) 126–140 (n = 306) 141–158 (n = 286) ≥159 (n = 289)
Age (mean years ± SD) 70.2 ± 12.5 67.4 ± 12.2 68.4 ± 12.7 67.2 ± 12.0 66.8 ± 12.8 0.005
Male  (%) 211 (70.3) 222 (75.5) 226 (73.9) 213 (74.5) 214 (74.0) 0.671
Previous MI  (%) 49 (16.3) 43 (14.6) 29 (9.5) 26 (9.1) 22 (7.6) 0.002
Risk  factors
Smoking (%) 116 (38.7) 125 (42.5) 139 (45.4) 130 (45.5) 105 (36.3) 0.090
Hypercholesterolemia (%) 116 (38.7) 122 (41.5) 128 (41.8) 135 (47.2) 130 (45.0) 0.263
Hypertension (%) 156 (52.0) 157 (53.4) 178 (58.2) 169 (59.1) 207 (71.6) <0.001
Diabetes mellitus (%) 92 (30.7) 76 (25.9) 80 (26.1) 86 (30.1) 106 (36.7) 0.029
eGFR  (mL/min/1.73 m2) 57.9 ± 34.4 67.9 ± 23.9 70.6 ± 23.4 72.7 ± 24.7 71.7 ± 35.4 <0.001
CKD  (%) 177 (59.4) 103 (35.3) 84 (27.8) 84 (29.4) 82 (28.6) <0.001
Heart  rate at admission (bpm) 62.8 ± 30.5 71.0 ± 19.3 75.5 ± 19.1 77.6 ± 18.2 82.7 ± 20.7 <0.001
Killip  3/4 (%) 30/95 (41.7) 14/10 (8.2) 11/12 (7.5) 6/11 (5.9) 17/11 (9.7) <0.001
Data on admission heart rate were available in 285 of the 300 patients with SBP < 105 mmHg, 292 of the 294 patients with SBP 105–125 mmHg, 300 of the 306 patients with
SBP  126–140 mmHg, 283 of the 286 patients with SBP 141–158 mmHg, and 282 of the 289 patients with SBP ≥ 159 mmHg. Data on eGFR at admission were available in 298
of  the 300 patients with SBP < 105 mmHg, 292 of the 294 patients with SBP 105–125 mmHg, 302 of the 306 patients with SBP 126–140 mmHg, 286 of the 286 patients with
SBP  141–158 mmHg, and 287 of the 289 patients with SBP ≥ 159 mmHg. SBP, systolic blood pressure; MI,  myocardial infarction; eGFR, estimated glomerular ﬁltration rate;
CKD,  chronic kidney disease.
Table 2
Angiographic ﬁndings by systolic blood pressure at admission.
Systolic blood pressure at admission quintile (mmHg) p value
<105 (n = 300) 105–125 (n = 294) 126–140 (n = 306) 141–158 (n = 286) ≥159 (n = 289)
Culprit lesions
RCA (%) 155 (51.7) 128 (43.5) 102 (33.3) 91 (31.8) 52 (18.0) <0.001
LAD  (%) 74 (24.7) 116 (39.5) 150 (49.0) 142 (49.7) 178 (61.2)
LCx  (%) 24 (8.0) 37 (12.6) 43 (14.1) 43 (15.0) 48 (16.6)
LMT  (%) 28 (9.3) 4 (1.4) 1 (0.3) 3 (1.0) 5 (1.7)
Multivessels (%) 18 (6.0) 9 (3.1) 9 (2.9) 7 (2.4) 6 (2.1)
SVG  1 (0.3) 0 (0.0) 1 (0.3) 0 (0.0) 0 (0.0)
No.  of diseased vessels
1 (%) 147 (49.0) 178 (60.5) 180 (58.8) 175 (61.2) 179 (61.9) <0.001
2  (%) 82 (27.3) 84 (28.6) 86 (28.1) 82 (28.7) 73 (25.3)
3  (%) 49 (16.3) 30 (10.2) 39 (12.7) 26 (9.1) 32 (11.1)
LMT  (%) 22 (7.3) 2 (0.7) 1 (0.3) 3 (1.0) 5 (1.7)
CAG, coronary angiography; RCA, right coronary artery; LAD, left anterior descending coronary artery; LCx, left circumﬂex coronary artery; LMT, left main trunk; SVG,
saphenous vein graft.
Table 3
Results of coronary intervention by systolic blood pressure at admission.
Systolic blood pressure at admission quintile (mmHg) p value
<105 (n = 300) 105–125 (n = 294) 126–140 (n = 306) 141–158 (n = 286) ≥159 (n = 289)
Pre TIMI grade
0 196 (65.6) 174 (59.6) 163 (54.0) 173 (61.6) 143 (50.2) <0.001
1  43 (14.4) 29 (9.9) 42 (13.9) 25 (8.9) 28 (9.8)
2  22 (7.4) 49 (16.8) 55 (18.2) 40 (14.2) 53 (18.6)
3  38 (12.7) 40 (13.7) 42 (13.9) 43 (15.3) 61 (21.4)
Post  TIMI grade
0  5 (1.7) 3 (1.0) 2 (0.7) 6 (2.1) 3 (1.1) 0.139
1  6 (2.0) 5 (1.7) 3 (1.0) 1 (0.4) 0 (0.0)
2  22 (7.4) 18 (6.2) 13 (4.3) 17 (6.0) 10 (3.5)
3  266 (89.0) 266 (90.5) 284 (94.0) 257 (91.5) 272 (95.4)
Stent  (%) 261 (87.0) 262 (89.1) 271 (88.6) 249 (87.1) 245 (84.8) 0.555
IABP  (%) 93 (31.0) 40 (13.6) 27 (8.8) 27 (9.4) 23 (8.0) <0.001
PCPS  (%) 31 (10.3) 3 (1.0) 1 (0.3) 0 (0.0) 2 (0.7) <0.001
Pacing (%) 75 (25.0) 36 (12.2) 16 (5.2) 16 (5.6) 4 (1.4) <0.001
D g, 29
1  289 p
m iopul
g
a
a
I
Tata on TIMI grade were available in 299 of the 300 patients with SBP < 105 mmH
26–140 mmHg, 281 of the 286 patients with SBP 141–158 mmHg, and 285 of the
yocardial infarction; IABP, intra-aortic balloon pumping; PCPS, percutaneous card
rade in the IRA before primary PCI and higher frequency of intra-
ortic balloon pumping, percutaneous cardiopulmonary support,
nd temporary pacing during procedures and/or admission period.n-hospital outcomes
Table 4 shows the in-hospital prognoses in the 5 groups.
he patients with lower admission SBP were likely to have2 of the 294 patients with SBP 105–125 mmHg, 302 of the 306 patients with SBP
atients with SBP ≥ 159 mmHg. SBP, systolic blood pressure; TIMI, thrombolysis in
monary support.
a higher value of peak creatine phosphokinase (CK) con-
centration. Patients with SBP < 105 mmHg had a signiﬁcantly
higher mortality, while mortality was not signiﬁcantly dif-
ferent among the other quintiles: 24.3% (<105 mmHg), 4.8%
(105–125 mmHg), 4.9% (126–140 mmHg), 2.8% (141–158 mmHg),
and 5.2% (≥159 mmHg) (p < 0.001). Among the patients with Killip
1, there was  also a similar tendency in the relationship between
admission SBP and in-hospital mortality: 9.0% (<105 mmHg,
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Table 5
Predictors of in-hospital mortality in the study patients (multivariate logistic regres-
sion analysis). (A) Admission SBP < 105 mmHg  was included as a variable. (B)
Admission SBP 141–158 mmHg was included as a variable.
OR 95% CI p value
(A)
Killip 3/4 6.948 4.221–11.436 <0.0001
Multi-vessels or LMT  as culprit 2.938 1.516–5.695 0.0014
SBP < 105 mmHg  2.533 1.544–4.128 0.0002
CKD 1.703 1.048–2.765 0.0315
Age 1.044 1.021–1.068 0.0001
TIMI 3 before PCI 0.459 0.209–1.008 0.0523
TIMI 3 after PCI 0.241 0.131–0.446 <0.0001
No.  of diseased vessels ≥ 2 or LMT 1.141 0.690–1.886 0.6077
Male 0.757 0.458–1.251 0.2774
Previous MI  1.410 0.774–2.569 0.2609
(B)
Killip 3/4 8.765 5.470–14.046 <0.0001
Multi-vessels or LMT  as culprit 3.382 1.763–6.491 0.0002
CKD 2.020 1.257–3.247 0.0037
SBP 141–158 mmHg  0.361 0.162–0.804 0.0126
Age 1.042 1.019–1.065 0.0003
TIMI 3 before PCI 0.408 0.187–0.890 0.0243
TIMI 3 after PCI 0.231 0.126–0.422 <0.0001
Hypercholesterolemia 0.609 0.372–0.996 0.0479
No.  of diseased vessels ≥ 2 or LMT 1.119 0.680–1.843 0.6581
Male 0.738 0.448–1.217 0.2334
Previous MI  1.552 0.860–2.801 0.1447
OR, odds ratio; CI, conﬁdence interval; SBP, systolic blood pressure; CKD, chronic
kidney disease; PCI, percutaneous coronary intervention; LMT, left main trunk; MI,
myocardial infarction.n = 145), 3.1% (105–125 mmHg, n = 229), 1.3% (126–140 mmHg,
n = 235), 0.4% (141–158 mmHg, n = 236), and 2.2% (≥159 mmHg,
n = 232) (p < 0.001). The SBP-associated trends in cardiac-related
death as well as noncardiac-related death coincided with that
in overall death. Deaths ascribed to cardiogenic shock, conges-
tive heart failure, and ventricular ﬁbrillation were common in
the patients with SBP < 105 mmHg, while death associated with
ventricular rupture was frequent not only in the patients with
lower SBP but also in the patients with SBP ≥ 159 mmHg. In
order to assess the contribution of clinical background, risk fac-
tors, angiographic ﬁndings, results of primary PCI, and SBP at
admission, univariate and multivariate logistic regression anal-
yses were developed for overall death during hospitalization.
Potent variables included age, gender, medical history (previous MI,
CKD, smoking, hypercholesterolemia, hypertension, and diabetes
mellitus), angiographic ﬁndings (multi-vessels or LMT  as culprit
lesions, and number of diseased vessels ≥ 2 or diseased LMT), PCI
results (TIMI 3 ﬂow before/immediately after primary PCI, and
stent usage), Killip class ≥ 3 at admission, and SBP < 105 mmHg,
SBP 105–125 mmHg, SBP 126–140 mmHg, SBP 141–158 mmHg, or
SBP ≥ 159 mmHg  at admission. On univariate testing, except for
hypertension (p = 0.1085) and diabetes mellitus (p = 0.1162), all
variables mentioned above were associated with in-hospital death
(p < 0.05). Taking clinical signiﬁcance of hypertension and diabetes
mellitus into consideration, all the available variables described
above were therefore entered into multivariate models. On multi-
variate analysis, Killip class ≥ 3 at admission, LMT  or multivessels as
culprit lesions, admission SBP < 105 mmHg, CKD, and age were the
independent positive predictors of in-hospital mortality, whereas
admission SBP 141–158 mmHg  and TIMI 3 ﬂow after PCI were
the negative ones (Table 5A and B). In contrast, admission SBP
105–125 mmHg  (OR, 0.671, 95% CI, 0.349–1.289), admission SBP
126–140 mmHg  (OR 0.855, 95% CI 0.458–1.596), and admission
SBP ≥ 159 mmHg  (OR 0.923, 95% CI 0.480–1.776) were not tightly
associated with in-hospital death.
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The major ﬁndings of the present multicenter study are as fol-
ows: among AMI patients undergoing primary PCI, patients with
BP < 105 mmHg  had a signiﬁcantly higher mortality, while mortal-
ty was not signiﬁcantly different among the other quintiles: 24.3%
<105 mmHg), 4.8% (105–125 mmHg), 4.9% (126–140 mmHg), 2.8%
141–158 mmHg), and 5.2% (≥159 mmHg) (p < 0.001); on multivari-
te analysis, Killip class ≥ 3 at admission, LMT  or multivessels as
ulprit lesions, admission SBP < 105 mmHg, CKD, and age were the
ndependent positive predictors of in-hospital mortality, whereas
dmission SBP 141–158 mmHg  and TIMI 3 ﬂow after PCI were the
egative ones, but admission SBP 105–125 mmHg, admission SBP
26–140 mmHg, and admission SBP ≥ 159 mmHg were not.
This study is the ﬁrst to investigate the prognostic impact of SBP
t admission on in-hospital prognosis among AMI  patients under-
oing primary PCI in Japan. We  have already demonstrated that in
verall AMI patients with elapsed time <24 h after onset, admission
BP 141–159 mmHg  might be correlated with better in-hospital
rognosis, whereas admission SBP < 106 mmHg  was associated
ith in-hospital death [9]. In the previous study, undergoing pri-
ary PCI was an independent negative predictor of in-hospital
eath, and there was a tendency that patients with higher SBP
ere prone to have higher prevalence of TIMI 3 ﬂow in the infarct-
elated coronary artery before/after PCI [9].  Thus, taking TIMI 3
ow before/after PCI as variables into the multivariate analysis, we
eevaluated prognostic impact of admission SBP on in-hospital out-
ome exclusively in the AMI  patients undergoing PCI. Even in the
resent report concerning the primary PCI-treated AMI  patients,
here was a similar tendency in the relationship between admis-
ion SBP and in-hospital outcome. In contrast, numerous studies
n Western countries have shown that the higher the SBP is at
dmission, the better the prognosis of AMI  patients [5–8], and
ndeed admission SBP is involved in several risk-scoring methods
or AMI  patients [12–17].  Since SBP is supposed to represent a com-
ined product of cardiac output and systemic peripheral resistance,
igher SBP at admission might reﬂect not only a larger systemic
esistance but also a preserved systolic ventricular function with
esser myocardial injury in AMI  patients. In the present report, the
atients with SBP < 105 mmHg  tended to have higher age, previous
I,  CKD, Killip class ≥ 3 at admission, lower heart rate at admis-
ion, RCA, LMT, or multivessels as culprit lesions, larger number of
iseased vessels, lower TIMI grade in the IRA before primary PCI,
igher value of peak CK concentration and a signiﬁcantly higher
n-hospital mortality rate. However, inconsistent with the reports
rom US and European investigators, the patients with admission
BP 141–158 mmHg  might have better in-hospital outcome among
apanese AMI patients undergoing primary PCI.
The mechanism in which admission SBP 141–158 mmHg, not
dmission SBP ≥ 159 mmHg, was associated with better in-hospital
utcome remains unclear. On the point of view of peak CK value, the
xtent of myocardial damage was inversely correlated with admis-
ion SBP, and indeed prevalence of in-hospital deaths due to shock
as also almost inversely correlated with admission SBP. In con-
rast, deaths ascribed to heart failure or ventricular rupture were
are in the patients with SBP 141–158 mmHg, while those deaths
ere more frequent in the patients with SBP ≥ 159 mmHg  as well
s in the patients with lower SBP. The patients with admission
BP ≥ 159 mmHg  had higher prevalence of left anterior descend-
ng coronary artery (LAD) as culprit lesions than the patients with
BP 141–158 mmHg. In addition, although data regarding SBP dur-
ng admission period are missing, there is a possibility that heart
ailure due to afterload mismatch might be prone to occur in
he patients with admission SBP ≥ 159 mmHg. Indeed, the patients
ith admission SBP ≥ 159 mmHg  had a higher frequency of Kil-
ip 3 than the patients with SBP 141–158 mmHg. Furthermore,iology 60 (2012) 139–144 143
since hypertension, advanced age, female gender, lower body mass
index, delayed reperfusion, ﬁrst AMI, 1-vessel disease with pre-
served left ventricular function, totally occluded LAD as culprit,
and small myocardial infarction due to branch occlusion have been
reported to be associated with cardiac rupture [18–20],  the patients
with SBP ≥ 159 mmHg  characterized by smaller peak CK as well as
higher prevalence of hypertension, ﬁrst AMI, LAD as culprit, and 1-
vessel disease, might therefore be at high risk of ventricular rupture.
Taken together, increased cardiac deaths due to heart failure and
ventricular rupture might contribute in part to relatively high in-
hospital mortality in the patients with admission SBP ≥ 159 mmHg.
Another potential explanation is that larger frequency of diabetes
mellitus might account for relatively high in-hospital mortality
in the patients with admission SBP ≥ 159 mmHg. Presence of dia-
betes mellitus might affect clinical course of coexisting non-cardiac
disease, such as infection or renal failure. Indeed, non-cardiac
deaths are also more prevalent in the patients with admission
SBP ≥ 159 mmHg  than in the patients with SBP 141–158 mmHg.
Immediate risk stratiﬁcation is necessary for appropriate emer-
gency treatment in AMI  patients. Several risk scoring models have
been proposed by US and European investigators, and a number
of constitutive factors, which could be easily obtainable variables
at the ﬁrst patient contact in the emergency room, such as clini-
cal presentation (cardiac arrest at arrival), gender, age, SBP, heart
rate, Killip class, renal function, ST deviation, QRS duration, ante-
rior MI,  cardiac enzyme elevation, and/or cardiovascular risk were
involved in those models [12–17]. Accumulating clinical evidence
has demonstrated an inverse relation between SBP and in-hospital
prognosis in AMI  patients, and SBP has been therefore regarded
as a major component in those risk-scoring methods. Even in the
present report, the patients with lowest SBP quintile had a high-
est in-hospital mortality rate and highest prevalence of deaths due
to cardiogenic shock in particular. Thus, although data regarding
nonfatal cardiogenic shock were lacking in the present report, it is
also important for in-hospital survival to recognize high-risk AMI
patients prone to cardiogenic shock. However, there are few data
regarding the relationship between admission SBP and prognosis
among Japanese AMI  patients [9],  and a prognostic risk-scoring
system has not yet been established for Japanese patients with
AMI. Further detailed, prospective, and long-term follow-up stud-
ies are necessary to examine prognostic effects of admission SBP
and to produce a prognostic risk assessment model in Japanese AMI
patients.
Study limitations
First, this is a retrospective observational analysis of a relatively
small number of patients. Second, data regarding clinical back-
ground and angiographic results of primary PCI were not available
for all the study population. Third, we  did not have enough detailed
data regarding left ventricular function, elapsed time, ischemic
time, and in-hospital medical treatment, which might be signiﬁ-
cant predictors of in-hospital death. In particular, anti-hypertensive
treatments in the pre-admission period might signiﬁcantly affect
admission SBP. Fourth, “ST-elevation MI”  was not distinguished
from “non-ST-elevation MI”. Fifth, we  did not have enough data
regarding non-fatal major adverse cardiovascular events during
the admission period. Sixth, data concerning an individual deci-
sive factor of primary PCI for the patients with elapsed time > 12 h
were lacking. Seventh, we did not have enough data about 30-day
mortality as an endpoint in the present study population.Conclusion
The present study suggests that among Japanese AMI  patients
undergoing primary PCI admission SBP 141–158 mmHg  might be
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The following institutions and principal investigators partici-
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ospital: Fujita H, Inoue K, Matsuo A, Sakatani T, Tsubakimoto Y;
ocial Insurance Kyoto Hospital: Yamada C, Oda Y, Tanabe S; Tanabe
entral Hospital: Kusuoka S, Takechi N, Nishizawa S; Nantan Gen-
ral Hospital: Tatsumi T, Keira N, Nishikawa S, Nomura T; Ayabe
unicipal Hospital: Shiga K, Kohno Y, Adachi Y; Maizuru Medical
enter: Harada Y, Hikosaka T, Nakagami T; Kyoto Saiseikai Hospital:
amahara Y, Ishibashi K, Takeda M;  Gakkentoshi Hospital: Sakai R,
kashi K; Kouseikai Takeda Hospital: Matsumoto K, Kinoshita N,
awanishi T, Nakamura R; Kameoka Municipal Hospital: Matsuo R;
iseikai Yamashina Hospital: Yamamoto T; Fukuchiyama Munici-
al Hospital: Nishio M,  Sakamoto T; Kyoto Prefectural Yosanoumi
ospital: Honsho S, Isodono K; Kyoto Prefectural University School
f Medicine: Shiraishi H, Yamano T.
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